Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)
September 16 2016 - 6:06AM
Edgar (US Regulatory)
Filed Pursuant to Rule 433
Registration No. 333-194298
GILEAD SCIENCES, INC.
PRICING TERM SHEET
Dated September 15, 2016
|
|
|
Issuer:
|
|
Gilead Sciences, Inc.
|
|
|
Title of Securities:
|
|
1.950% Senior Notes due 2022 (the 2022 Notes)
2.500% Senior Notes due 2023 (the 2023 Notes)
2.950%
Senior Notes due 2027 (the 2027 Notes)
4.000% Senior Notes due 2036 (the 2036 Notes)
4.150% Senior Notes due 2047 (the 2047 Notes)
|
|
|
Principal Amount:
|
|
2022 Notes: $500,000,000
2023 Notes:
$750,000,000
2027 Notes: $1,250,000,000
2036 Notes:
$750,000,000
2047 Notes: $1,750,000,000
|
|
|
Trade Date:
|
|
September 15, 2016
|
|
|
Original Issue Date (Settlement Date):
|
|
September 20, 2016
|
|
|
Maturity Date:
|
|
2022 Notes: March 1, 2022
2023 Notes: September
1, 2023
2027 Notes: March 1, 2027
2036 Notes: September 1,
2036
2047 Notes: March 1, 2047
|
|
|
Interest Rate:
|
|
2022 Notes: 1.950%
2023 Notes: 2.500%
2027 Notes: 2.950%
2036 Notes: 4.000%
2047 Notes: 4.150%
|
|
|
Price to Public:
|
|
2022 Notes: 99.769%
2023 Notes: 99.646%
2027 Notes: 99.974%
2036 Notes: 99.430%
2047 Notes: 99.283%
|
|
|
Yield to Maturity:
|
|
2022 Notes: 1.995%
2023 Notes: 2.556%
2027 Notes: 2.953%
2036 Notes: 4.042%
2047 Notes: 4.192%
|
|
|
|
|
|
Spread to Benchmark Treasury:
|
|
2022 Notes: 80 basis points
2023
Notes: 105 basis points
2027 Notes: 125 basis points
2036 Notes: 157 basis points
2047 Notes: 172 basis
points
|
|
|
Benchmark Treasury:
|
|
2022 Notes: 1.125% due August 31, 2021
2023
Notes: 1.375% due August 31, 2023
2027 Notes: 1.500% due August 15, 2026
2036 Notes: 2.500% due May 15, 2046
2047 Notes: 2.500% due May
15, 2046
|
|
|
Benchmark Treasury Price /Yield:
|
|
2022 Notes: 99-21
1
⁄
4
/ 1.195%
2023 Notes: 99-04+ / 1.506%
2027 Notes: 98-05 / 1.703%
2036 Notes: 100-18+ / 2.472%
2047 Notes: 100-18+ /
2.472%
|
|
|
Interest Payment Dates:
|
|
2022 Notes: March 1 and September 1, commencing March 1, 2017
2023 Notes: March 1 and September 1, commencing March 1, 2017
2027 Notes: March 1 and September 1, commencing March 1, 2017
2036 Notes: March 1 and September 1, commencing March 1, 2017
2047 Notes: March 1 and September 1, commencing March 1, 2017
|
|
|
Make-Whole Call:
|
|
2022 Notes: At any time prior to February 1, 2022 at a discount rate of Treasury plus 12.5 basis points;
2023 Notes: At any time prior to July 1, 2023 at a discount rate of Treasury plus 15 basis points;
2027 Notes: At any time prior to December 1, 2026 at a discount rate of Treasury plus 20 basis points;
2036 Notes: At any time prior to March 1, 2036 at a discount rate of Treasury plus 25 basis points;
2047 Notes: At any time prior to September 1, 2046 at a discount rate of Treasury plus 25 basis points;
|
|
|
Par Call:
|
|
2022 Notes: On or after February 1, 2022
2023
Notes: On or after July 1, 2023
2027 Notes: On or after December 1, 2026
2036 Notes: On or after March 1, 2036
2047 Notes: On or after
September 1, 2046
|
|
|
CUSIP / ISIN:
|
|
2022 Notes: 375558 BH5 / US375558BH51
2023
Notes: 375558 BL6 / US375558BL63
2027 Notes: 375558 BM4 / US375558BM47
2036 Notes: 375558 BJ1 / US375558BJ18
2047 Notes: 375558 BK8 /
US375558BK80
|
|
|
|
|
|
Joint Book-Running Managers:
|
|
Merrill Lynch, Pierce, Fenner & Smith
Incorporated
J.P. Morgan Securities LLC
Barclays Capital Inc. (2036 Notes,
2047 Notes)
Goldman, Sachs & Co. (2036 Notes, 2047 Notes)
Wells Fargo Securities, LLC (2036 Notes, 2047 Notes)
HSBC
Securities (USA) Inc. (2022 Notes, 2023 Notes, 2027 Notes)
Mizuho Securities USA Inc. (2022 Notes, 2023 Notes, 2027 Notes)
SMBC Nikko Securities America, Inc. (2022 Notes, 2023 Notes, 2027 Notes)
|
|
|
Co-Managers:
|
|
Citigroup Global Markets Inc.
Morgan Stanley
& Co. LLC
MUFG Securities Americas Inc.
RBC Capital
Markets, LLC
U.S. Bancorp Investments, Inc.
Lazard
Frères & Co. LLC
Evercore Group L.L.C.
The
Williams Capital Group, L.P.
|
The issuer has filed a registration statement (including a prospectus) and a prospectus supplement with the SEC for the
offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the prospectus supplement and other documents the issuer has filed with the SEC for more complete information about the
issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you
request it by calling Merrill Lynch, Pierce, Fenner & Smith Incorporated toll-free at 1-800-294-1322 or calling J.P. Morgan Securities LLC at 1-212-834-4533.
This pricing term sheet supplements the Preliminary Prospectus Supplement issued by Gilead Sciences, Inc. on September 15, 2016 relating to its
Prospectus dated March 4, 2014.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Sep 2023 to Sep 2024